Adocia (LTS:0QAI) Accumulated Depreciation: €-6.68 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QAI Adocia LTS:0QAI
29 GF Score
Price €4.03
GF Value €0.86
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Adocia Accumulated Depreciation?

Adocia LTS:0QAI +1.67% 29 Accumulated Depreciation is €-6.68 Mil as of Dec. 2025. GuruFocus rates LTS:0QAI with a GF Score™ of 29/100 and a GF Value™ of €0.86 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Adocia's quarterly accumulated depreciation increased from Dec. 2024 (€-6.31 Mil) to Jun. 2025 (€-6.56 Mil) and increased from Jun. 2025 (€-6.56 Mil) to Dec. 2025 (€-6.68 Mil).

Adocia's annual accumulated depreciation increased from Dec. 2023 (€-5.89 Mil) to Dec. 2024 (€-6.31 Mil) and increased from Dec. 2024 (€-6.31 Mil) to Dec. 2025 (€-6.68 Mil).

Adocia Accumulated Depreciation Related Terms

Adocia Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Adocia's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adocia Accumulated Depreciation Chart

Adocia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.10 -3.56 -5.89 -6.31 -6.68

Adocia Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.11 -6.31 -6.56 -6.68 0.00
LTS:0QAI
29GF Score
Adocia LTS:0QAI
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adocia Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of €-6.68 Mil mean?
Adocia (LTS:0QAI) has a Accumulated Depreciation of €-6.68 Mil as of Dec. 2025. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Adocia and its competitors.
Is Adocia's Accumulated Depreciation too high?
Adocia's current Accumulated Depreciation is €-6.68 Mil. Overall, Adocia has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Adocia's Accumulated Depreciation compare to VRTX and REGN?
Adocia's Accumulated Depreciation of €-6.68 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Biotechnology company?
A good Accumulated Depreciation depends on the Biotechnology industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Adocia and its competitors. Adocia's current Accumulated Depreciation is €-6.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adocia stock overvalued right now?
Based on GuruFocus' analysis, Adocia (LTS:0QAI) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.86, compared to a current price of €4.03 — trading 368.4% above its estimated fair value. The current Accumulated Depreciation is €-6.68 Mil. Adocia's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Adocia (LTS:0QAI), the current Accumulated Depreciation is €-6.68 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adocia (LTS:0QAI) Overvalued in 2026?

Based on GuruFocus' analysis, Adocia stock appears to be overvalued. The current stock price of €4.03 is trading 368.4% above its estimated GF Value™ of €0.86. GuruFocus considers Adocia to be Significantly Overvalued.

Key valuation signals for LTS:0QAI:

  • Accumulated Depreciation: €-6.68 Mil
  • GF Value™: €0.86 vs. price of €4.03 (368.4% above fair value)
  • GF Score™: 29/100 with 7 warning signs

No single metric tells the full story. See the LTS:0QAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adocia Business Description

Other Exchanges ADOC:FranceA89:Germany
Address 115 Avenue Lacassagne, Lyon, FRA, 69003
Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The firm has developed Biochaperone, a proprietary technology platform to enhance the effectiveness of therapeutic proteins. The company's clinical pipeline includes Biochaperone Lispro, Biochaparone Combo, Biochaparone Glucagon, and others. Its pre-clinical pipeline includes BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.
29GF Score

Get the complete analysis for LTS:0QAI

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.03
Price
€0.86
GF Value